Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P. Kim Kamdar

Affiliations

  • Director at Obalon Therapeutics Inc (OBLN), 2019-08-08
  • Director at Evofem Biosciences Inc. (EVFM), 2019-06-07
  • Large Shareholder at Bionano Genomics Inc (BNGO), 2018-08-21
  • Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2017-12-13
  • Large Shareholder at Tobira Therapeutics Inc. (TBRA), 2016-11-04
  • Large Shareholder, Director at Syndax Pharmaceuticals Inc (SNDX), 2016-11-02
  • Large Shareholder at Glaukos Corp (GKOS), 2015-06-24
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-07
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2014-07-31
  • Large Shareholder at Aldeyra Therapeutics Inc. (ALDX), 2014-05-01
  • Large Shareholder at Cadence Pharmaceuticals Inc (CADX), 2014-03-21
  • Large Shareholder at Evoke Pharma Inc (EVOK), 2013-09-24
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2013-06-25
  • Large Shareholder at Celator Pharmaceuticals Inc (NONE), 2013-01-15
  • Large Shareholder at Achillion Pharmaceuticals Inc (ACHN), 2012-01-18
  • Large Shareholder at Orexigen Therapeutics Inc. (OREX), 2012-01-18
  • Large Shareholder at Zogenix Inc. (ZGNX), 2012-01-18
  • Large Shareholder at Clovis Oncology Inc. (CLVS), 2011-11-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OBLN $4.00 12,500 Director 27,148 2019-08-06 Filing
OBLN $1.82 54,945 Director 68,345 2018-08-23 Filing
OBLN $15.00 13,400 Director 13,400 2016-10-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EVFM $5.07 655 Director 0 2019-05-21 Filing